Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

2015589 citationsJournal Article

Authors

Heterologous prime/boost with Cy/GVAX and CRS-207 extended survival for patients with pancreatic cancer, with minimal toxicity.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 33, Issue 12, pp. 1325-1333

Field-Weighted Citation Impact: 35.20